HUE047062T2 - Angiotenzin II alacsony vérnyomás kombinációs kezelésére - Google Patents
Angiotenzin II alacsony vérnyomás kombinációs kezeléséreInfo
- Publication number
- HUE047062T2 HUE047062T2 HUE14872684A HUE14872684A HUE047062T2 HU E047062 T2 HUE047062 T2 HU E047062T2 HU E14872684 A HUE14872684 A HU E14872684A HU E14872684 A HUE14872684 A HU E14872684A HU E047062 T2 HUE047062 T2 HU E047062T2
- Authority
- HU
- Hungary
- Prior art keywords
- hypotension
- angiotensin
- treatment
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361917576P | 2013-12-18 | 2013-12-18 | |
US201461955706P | 2014-03-19 | 2014-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE047062T2 true HUE047062T2 (hu) | 2020-04-28 |
Family
ID=53367119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE14872684A HUE047062T2 (hu) | 2013-12-18 | 2014-12-18 | Angiotenzin II alacsony vérnyomás kombinációs kezelésére |
Country Status (23)
Country | Link |
---|---|
US (7) | US9220745B2 (pt-PT) |
EP (2) | EP2986308B1 (pt-PT) |
JP (3) | JP6824739B2 (pt-PT) |
KR (3) | KR20220028125A (pt-PT) |
CN (3) | CN106061493A (pt-PT) |
AU (2) | AU2014364528C1 (pt-PT) |
BR (1) | BR112016013961A2 (pt-PT) |
CA (1) | CA2933601A1 (pt-PT) |
CY (1) | CY1122604T1 (pt-PT) |
DK (1) | DK2986308T3 (pt-PT) |
EA (1) | EA037823B1 (pt-PT) |
ES (1) | ES2771749T3 (pt-PT) |
HR (1) | HRP20200009T1 (pt-PT) |
HU (1) | HUE047062T2 (pt-PT) |
IL (1) | IL246162B (pt-PT) |
LT (1) | LT2986308T (pt-PT) |
MX (2) | MX2016008108A (pt-PT) |
NZ (1) | NZ721089A (pt-PT) |
PL (1) | PL2986308T3 (pt-PT) |
PT (1) | PT2986308T (pt-PT) |
RS (1) | RS59804B1 (pt-PT) |
SI (1) | SI2986308T1 (pt-PT) |
WO (1) | WO2015095535A1 (pt-PT) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9572856B2 (en) | 2009-12-16 | 2017-02-21 | The George Washington University a Congressionally Chartered Not-for-Profit Corporation | Method of treating low blood pressure |
WO2015095535A1 (en) | 2013-12-18 | 2015-06-25 | The George Washington University, A Congressional Chartered Not-For-Profit Corporation | Angiotensin ii alone or in combination for the treatment of hypotension |
JP2017519799A (ja) * | 2014-07-08 | 2017-07-20 | ラ ホヤ ファーマシューティカル カンパニーLa Jolla Pharmaceutical Company | 低血圧の治療方法 |
US9919022B2 (en) | 2015-03-20 | 2018-03-20 | Arthur J. ATKINSON, JR. | Use of angiotensin II (AII) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps |
JP2019508378A (ja) * | 2016-01-07 | 2019-03-28 | ラ ホヤ ファーマシューティカル カンパニーLa Jolla Pharmaceutical Company | 昇圧薬の投与方法 |
US10406201B2 (en) | 2016-01-07 | 2019-09-10 | La Jolla Pharma, Llc | Methods for administering angiotensin II |
WO2018191678A1 (en) * | 2017-04-14 | 2018-10-18 | La Jolla Pharmaceutical Company | Methods for administering angiotensin ii |
US20190183962A1 (en) * | 2017-12-15 | 2019-06-20 | La Jolla Pharma, Llc | Angiotensin compositions and methods related thereto |
WO2023244552A1 (en) * | 2022-06-15 | 2023-12-21 | Virginia Commonwealth University | Methods for fluid resuscitation of an organ donor |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU181008B (en) | 1980-01-18 | 1983-05-30 | Richter Gedeon Vegyeszet | Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position |
US5216025A (en) * | 1989-09-13 | 1993-06-01 | Board Of Regents, The University Of Texas System | Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
US5444067A (en) | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
CA2448051A1 (en) | 2001-06-04 | 2002-12-12 | Human Genome Sciences, Inc. | Methods and compositions for modulating ace-2 activity |
US7115266B2 (en) | 2001-10-05 | 2006-10-03 | Cytos Biotechnology Ag | Angiotensin peptide-carrier conjugates and uses thereof |
US7785566B2 (en) | 2003-11-06 | 2010-08-31 | Ge Healthcare, Inc. | Pharmaceutical compounds |
NO20034952D0 (no) | 2003-11-06 | 2003-11-06 | Amersham Health As | Farmasöytiske forbindelser |
FR2880807B1 (fr) * | 2005-01-19 | 2007-04-13 | Aguettant Sa Lab | Composition pharmaceutique injectable |
DE602006021600D1 (de) | 2005-09-29 | 2011-06-09 | Fibrogen Inc | Verfahren zur senkung des blutdrucks |
JP2009521513A (ja) * | 2005-12-30 | 2009-06-04 | ハワード・フロレイ・インスティチュート・オブ・エクスペリメンタル・フィスィオロジー・アンド・メディシン | 治療の方法 |
WO2007146900A2 (en) | 2006-06-15 | 2007-12-21 | Gilead Colorado, Inc. | Antihypertensive therapy method |
WO2008130217A1 (en) * | 2006-08-08 | 2008-10-30 | Applied Nanosystems B.V. | Cyclic angiotensin analogs |
CN101795675A (zh) | 2006-11-17 | 2010-08-04 | 达沃尔泰拉公司 | 使用具有Eudragit包衣的Zn/果胶珠粒进行的结肠递送 |
WO2009009907A1 (en) | 2007-07-18 | 2009-01-22 | The University Of British Columbia | Use of vasopressin-receptor agonists for the treatment of septic shock |
EP2161030A1 (en) * | 2008-09-09 | 2010-03-10 | Rijksuniversiteit te Groningen | Oxytocin formulations and uses thereof |
NZ606283A (en) | 2008-11-28 | 2014-08-29 | Abbvie Inc | Stable antibody compositions and methods for stabilizing same |
US9572856B2 (en) * | 2009-12-16 | 2017-02-21 | The George Washington University a Congressionally Chartered Not-for-Profit Corporation | Method of treating low blood pressure |
FR2959414B1 (fr) * | 2010-04-30 | 2016-01-08 | Luc Quintin | Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire |
EP2593541A4 (en) | 2010-07-14 | 2014-01-22 | Cumberland Emerging Technologies Inc | METHOD FOR THE TREATMENT OF HEPATORENAL SYNDROME AND HEPATIC ENZEPHALOPATHY WITH THROMBOXANE A2 RECEPTOR ANTAGONISTS |
EP3858437A1 (en) | 2013-04-26 | 2021-08-04 | La Jolla Pharma, LLC | Compositions and methods for treating renal failure |
WO2015095535A1 (en) | 2013-12-18 | 2015-06-25 | The George Washington University, A Congressional Chartered Not-For-Profit Corporation | Angiotensin ii alone or in combination for the treatment of hypotension |
US20150286797A1 (en) | 2014-04-02 | 2015-10-08 | David R. Ratto | System and method for administering medication |
JP2017519799A (ja) | 2014-07-08 | 2017-07-20 | ラ ホヤ ファーマシューティカル カンパニーLa Jolla Pharmaceutical Company | 低血圧の治療方法 |
US10406201B2 (en) | 2016-01-07 | 2019-09-10 | La Jolla Pharma, Llc | Methods for administering angiotensin II |
JP2019508378A (ja) | 2016-01-07 | 2019-03-28 | ラ ホヤ ファーマシューティカル カンパニーLa Jolla Pharmaceutical Company | 昇圧薬の投与方法 |
WO2018191678A1 (en) | 2017-04-14 | 2018-10-18 | La Jolla Pharmaceutical Company | Methods for administering angiotensin ii |
US20190183962A1 (en) | 2017-12-15 | 2019-06-20 | La Jolla Pharma, Llc | Angiotensin compositions and methods related thereto |
-
2014
- 2014-12-18 WO PCT/US2014/071186 patent/WO2015095535A1/en active Application Filing
- 2014-12-18 NZ NZ721089A patent/NZ721089A/en unknown
- 2014-12-18 CN CN201480075899.1A patent/CN106061493A/zh active Pending
- 2014-12-18 KR KR1020227004084A patent/KR20220028125A/ko active Application Filing
- 2014-12-18 EP EP14872684.7A patent/EP2986308B1/en active Active
- 2014-12-18 LT LTEP14872684.7T patent/LT2986308T/lt unknown
- 2014-12-18 BR BR112016013961A patent/BR112016013961A2/pt not_active Application Discontinuation
- 2014-12-18 RS RS20200021A patent/RS59804B1/sr unknown
- 2014-12-18 PT PT148726847T patent/PT2986308T/pt unknown
- 2014-12-18 EA EA201691258A patent/EA037823B1/ru unknown
- 2014-12-18 JP JP2016539318A patent/JP6824739B2/ja active Active
- 2014-12-18 EP EP19197866.7A patent/EP3607962A1/en active Pending
- 2014-12-18 CN CN202011494632.XA patent/CN112546197A/zh active Pending
- 2014-12-18 CA CA2933601A patent/CA2933601A1/en active Pending
- 2014-12-18 HU HUE14872684A patent/HUE047062T2/hu unknown
- 2014-12-18 ES ES14872684T patent/ES2771749T3/es active Active
- 2014-12-18 KR KR1020237012136A patent/KR20230051721A/ko not_active Application Discontinuation
- 2014-12-18 MX MX2016008108A patent/MX2016008108A/es unknown
- 2014-12-18 PL PL14872684T patent/PL2986308T3/pl unknown
- 2014-12-18 SI SI201431450T patent/SI2986308T1/sl unknown
- 2014-12-18 KR KR1020167019427A patent/KR102399383B1/ko active IP Right Grant
- 2014-12-18 CN CN202010824424.5A patent/CN111920939A/zh active Pending
- 2014-12-18 DK DK14872684.7T patent/DK2986308T3/da active
- 2014-12-18 US US14/575,127 patent/US9220745B2/en active Active
- 2014-12-18 AU AU2014364528A patent/AU2014364528C1/en active Active
-
2015
- 2015-11-13 US US14/941,301 patent/US10028995B2/en active Active
-
2016
- 2016-06-09 IL IL246162A patent/IL246162B/en active IP Right Grant
- 2016-06-17 MX MX2020011190A patent/MX2020011190A/es unknown
-
2018
- 2018-03-01 US US15/909,617 patent/US10493124B2/en active Active
- 2018-09-19 US US16/135,608 patent/US10765722B2/en active Active
-
2019
- 2019-04-12 US US16/382,850 patent/US11096983B2/en active Active
- 2019-08-23 JP JP2019153144A patent/JP7175506B2/ja active Active
-
2020
- 2020-01-03 HR HRP20200009TT patent/HRP20200009T1/hr unknown
- 2020-01-13 CY CY20201100026T patent/CY1122604T1/el unknown
- 2020-11-26 AU AU2020277230A patent/AU2020277230A1/en active Pending
-
2021
- 2021-07-20 US US17/380,311 patent/US11559559B2/en active Active
-
2022
- 2022-07-14 JP JP2022113327A patent/JP2022137224A/ja active Pending
-
2023
- 2023-01-23 US US18/157,933 patent/US20230226141A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201321743D0 (en) | Therapeutic agents | |
GB201321738D0 (en) | Therapeutic Agents | |
GB201321736D0 (en) | Therapeutic agents | |
GB201321729D0 (en) | Therapeutic agents | |
GB201321733D0 (en) | Therapeutic agents | |
GB201321728D0 (en) | Therapeutic agents | |
GB201321739D0 (en) | Therapeutic agents | |
GB201321730D0 (en) | Therapeutic agents | |
GB201321741D0 (en) | Therapeutic agents | |
IL246162A0 (en) | Angiotensin II, alone or in combination, to treat low blood pressure | |
GB201321740D0 (en) | Therapeutic agents | |
GB201321732D0 (en) | Therapeutic agents | |
GB201321734D0 (en) | Therapeutic Agents | |
GB201321737D0 (en) | Therapeutic Agents | |
GB201321744D0 (en) | Therapeutic agents | |
GB201321742D0 (en) | Therapeutic agents | |
HK1215164A1 (zh) | 處理方法 | |
GB201321735D0 (en) | Therapeutic Agents | |
GB201321745D0 (en) | Therapeutic agents | |
GB201304872D0 (en) | Treatment | |
GB201321731D0 (en) | Therapeutic agents | |
GB2516814B (en) | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer | |
HK1216391A1 (zh) | 組合治療 | |
GB201302839D0 (en) | Water Treatment | |
HK1209097A1 (en) | Water treatment |